- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Learning Session – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

Virtual Learning Session – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A
The presenters will discuss the history of psychedelics in therapeutic approaches with a primary focus on psilocybin. They will also review the neurobiology of psychedelics and the role of 5-HT2A receptors, review the results of recently published findings, and discuss the challenges associated with psychedelic-assisted therapies.
Featuring
-
Jessie Chambers, PhD
Medical Science Liaison
Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
Register
This event registration is closed.